Biotransformation profiles from a cohort of chronic fatigue women in response to a hepatic detoxification challenge
Authors:
Open Access
- 10 May 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0216298
Abstract
Chronic fatigue, in its various manifestations, frequently co-occur with pain, sleep disturbances and depression and is a non-communicable condition which is rapidly becoming endemic worldwide. However, it is handicapped by a lack of objective definitions and diagnostic measures. This has prompted the World Health Organization to develop an international instrument whose intended purpose is to improve quality of life (QOL), with energy and fatigue as one domain of focus. To complement this objective, the interface between detoxification, the exposome, and xenobiotic-sensing by nuclear receptors that mediate induction of biotransformation-linked genes, is stimulating renewed attention to a rational development of strategies to identify the metabolic profiles in complex multifactorial conditions like fatigue. Here we present results from a seven-year study of a cohort of 576 female patients suffering from low to high levels of chronic fatigue, in which phase I and phase II biotransformation was assessed. The biotransformation profiles used were based on hepatic detoxification challenge tests through oral caffeine, acetaminophen and acetylsalicylic acid ingestion coupled with oxidative stress analyses. The interventions indicated normal phase I but increased phase II glucuronidation and glycination conjugation. Complementarity was indicated between a fatigue scale, medical symptoms and associated energy-related parameters by application of Chi-square Automatic Interaction Detector (CHAID) analysis. The presented study provides a cluster of data from which we propose that multidisciplinary inputs from the combination of a fatigue scale, medical symptoms and biotransformation profiles provide the rationale for the development of a comprehensive laboratory instrument for improved diagnostics and personalized interventions in patients with chronic fatigue with a view to improving their QOL.Keywords
This publication has 68 references indexed in Scilit:
- The Human Urine MetabolomePLOS ONE, 2013
- Glycine conjugation: importance in metabolism, the role of glycine N -acyltransferase, and factors that influence interindividual variationExpert Opinion on Drug Metabolism & Toxicology, 2013
- Translational biomarker discovery in clinical metabolomics: an introductory tutorialMetabolomics, 2012
- The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivorsBreast Cancer Research and Treatment, 2012
- Environmental Determinants of Chronic Disease and Medical Approaches: Recognition, Avoidance, Supportive Therapy, and DetoxificationJournal of Environmental and Public Health, 2012
- Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement propertiesQuality of Life Research, 2011
- Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic statusMetabolomics, 2011
- Determinants of Aspirin Metabolism in Healthy Men and Women: Effects of Dietary Inducers of UDP-GlucuronosyltransferasesLifestyle Genomics, 2011
- Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health OrganizationSocial Science & Medicine, 1995